DODC

DODC
Identifiers
	IUPAC name 1-(2,5-dimethoxy-3,4-dichlorophenyl)propan-2-amine;
CAS Number	1373918-65-0;
PubChem CID	168429515;
ChemSpider	129432165;
UNII	JW779U7A4H;
Chemical and physical data
Formula	C11H15Cl2NO2
Molar mass	264.15 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES Clc1c(OC)cc(CC(C)N)c(OC)c1Cl;
	InChI InChI=1S/C11H15Cl2NO2/c1-6(14)4-7-5-8(15-2)9(12)10(13)11(7)16-3/h5-6H,4,14H2,1-3H3; Key:IGOFLAWWDQNRCV-UHFFFAOYSA-N;

DODC is a psychedelic drug from the substituted amphetamine family which acts as an agonist of the 5-HT_2A receptor. It is the 3,4-dichloro derivative of the well known psychedelic drug 2,5-dimethoxy-4-chloroamphetamine (DOC). DODC was first officially published in a patent filed by Gilgamesh Pharmaceuticals in 2020,^[1] though anecdotal reports suggest it had been synthesised by clandestine chemists and its activity established several years prior to this.

References

↑ WO 2022/006186, Kruegel AC, "Phenalkylamines and Methods of Treating Mood Disorders.", published January 2022, assigned to Gilgamesh Pharmaceuticals.

This hallucinogen-related article is a stub. You can help Wikipedia by adding missing information.